SCHEMBL8974782

SCHEMBL8974782

NS(=O)(=O)c1ccc(C2=CCC=C2c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 16/20 0.68
CA9 Q16790 14/20 0.68
CA12 O43570 12/20 0.68
CA1 P00915 12/20 0.68
CA14 Q9ULX7 4/20 0.54
CA7 P43166 2/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
PLA2G7 Q13093 1/20 0.54
CA13 Q8N1Q1 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
PTGS2 P35354 4/20 0.53
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
PTGS1 P23219 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974243 0.85 CA2 (0.71) CA2CA9CA12CA1CA14
SCHEMBL8974406 0.84 PTGS2 (0.60) CA2CA9CA12CA1CA7
SCHEMBL8974305 0.84 CA2 (0.64) CA2CA9CA12CA1CA14
SCHEMBL8973815 0.84 CA2 (0.52) CA2CA9CA12CA1CA14
SCHEMBL8974750 0.84 CA2 (0.64) CA2CA9CA12CA1CA14
SCHEMBL8974107 0.82 CA2 (0.69) CA2CA9CA12CA1CA7
SCHEMBL8974581 0.82 CA2 (0.57) CA2CA9CA12CA1CA14
SCHEMBL308881 0.82 CA2 (1.00) CA2CA9CA12CA1CA14
SCHEMBL6482321 0.82 CA2 (1.00) CA2CA9CA12CA1CA14
SCHEMBL8974499 0.81 PTGS2 (0.61) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed